comparemela.com

Intercept Announces FDA Acceptance of Supplemental New Drug Application for Ocaliva® (obeticholic acid) for the Treatment of PBC

Intercept Announces FDA Acceptance of Supplemental New Drug Application for Ocaliva® (obeticholic acid) for the Treatment of PBC

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Paul Nitschmann ,Drug Administration ,Advisory Committee ,Twitter ,Intercept Pharmaceuticals Inc ,Warfarinthe International Normalized Ratio ,Linkedin ,Regulatory Affairs At Intercept ,New Drug Application ,Prescription Drug User Fee Act ,Senior Vice President ,Regulatory Affairs ,Primary Biliary Cholangitisprimary ,Acid Binding Resinsbile ,International Normalized Ratio ,Narrow Therapeutic Indexobeticholic ,Bile Salt Efflux Pumpavoid ,Full Prescribing Information ,Intercept Pharmaceuticals ,

comparemela.com © 2020. All Rights Reserved.